Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Breast cancer vaccine - Anixa Biosciences/Cleveland Clinic

Next Previous
Drug Profile

Breast cancer vaccine - Anixa Biosciences/Cleveland Clinic

Alternative Names: Alpha-lactalbumin vaccine - Anixa Biosciences/Cleveland Clinic

Latest Information Update: 11 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cleveland Clinic
  • Developer Anixa Biosciences; Cleveland Clinic
  • Class Antineoplastics; Cancer vaccines; Immunotherapies; Peptide vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Triple negative breast cancer

Most Recent Events

  • 02 Jun 2025 Breast cancer vaccine is still in phase-I development in Triple-negative-breast-cancer in USA (SC, Injection)
  • 02 Jun 2025 Anixa Biosciences completes enrolment in its phase-I trial in Triple-negative-breast cancer in USA (SC) (NCT04674306)
  • 09 Apr 2025 USPTO issues notice of allowance for a patent covering breast cancer vaccine technology

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top